Cizzle Biotechnology Expands US Lab Partnership for CIZ1B Lung Cancer Test
UK diagnostics developer signs with multi-site laboratory group to scale commercial launch of early-stage lung cancer biomarker test across the United States.
UK diagnostics developer signs with multi-site laboratory group to scale commercial launch of early-stage lung cancer biomarker test across the United States.
Octave Bioscience's study demonstrates that its clinically validated MSDA Test enhances decision-making in managing multiple sclerosis.
Roche’s Tina-quant Lp(a) Gen.2 Molarity assay received FDA 510(k) clearance, supporting more precise cardiovascular risk assessment.
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
A biogel-based test uses bacteriophages to detect harmful bacteria in fluids quickly, accurately, and without the need for lab equipment.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...